LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectives
{{output}}
Major advances in understanding how genetics underlies Parkinson's disease (PD) have provided new opportunities for understanding disease pathogenesis and potential new targets for therapeutic intervention. One such target is leucine-rich repeat kinase 2 (LRRK... ...
